Login / Signup

Assessing the Clinical Utility of Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer.

Zachary Ryan McCawEthan Bernard LudmirLee-Jen Wei
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keyphrases
  • metastatic breast cancer
  • high dose